Imperial College London-医療機器分野:企業M&A・提携分析

◆英語タイトル:Imperial College London - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011123
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Imperial College London (Imperial) is a research university that offers educational services. The university provides undergraduate and postgraduate courses. It offers courses in the field of science and technology, agriculture, business, the humanities, and medicine. It conducts clinical trials in the therapeutic areas of cancer, cardiovascular and diabetes, emergency and critical care, HIV and infectious disease, surgery and robotics, and others. Imperial’s customized programs include finance, management, innovation and marketing, among others. The university offers collaborative research to promote connections between interests and research expertise. It also designs and conducts medical device trials. Imperial is headquartered in London, the UK.

Imperial College London – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Imperial College London, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Imperial College London, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Imperial College London, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Imperial College London, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Imperial College London, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Imperial College London, Medical Equipment, Deal Details 10
Partnerships 10
Natera Enters into Agreement with Imperial College London and University of Leicester 10
Smith & Nephew Enters into Agreement with Imperial College London 11
Owlstone Medical Enters into Agreement with Imperial College London 12
Mauna Kea Technologies Enters Into Co-Development With Imperial College London 13
Medical Research Council, Imperial College, King’s College and UCL Form Joint Venture 14
Imperial College London, King’s College London, University College London, Medical Research Council And GSK Form Joint Venture 15
Imperial College London – Key Competitors 17
Imperial College London – Key Employees 18
Imperial College London – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Recent Developments 20
Strategy And Business Planning 20
Jan 25, 2016: AstraZeneca partners with peers and academia to establish translational research fund 20
Government and Public Interest 21
Oct 12, 2016: Surgical procedure for aortic aneurysm associated with long-term mortality risk 21
Product News 23
Nov 02, 2017: Study of heart stents for stable angina highlights potential of placebo effect 23
Feb 06, 2017: Prosthetic arm technology that detects spinal nerve signals developed by scientists 25
Other Significant Developments 27
Feb 02, 2016: Heptares Launches “Orbit” Initiative – A New Collaborative Drug R&D Programme for Industry and Academia Focused on G Protein-Coupled Receptors (GPCRS) 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Imperial College London, Medical Equipment, Key Facts 2
Imperial College London, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Imperial College London, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Imperial College London, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Imperial College London, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Imperial College London, Deals By Market, 2011 to YTD 2017 8
Imperial College London, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Natera Enters into Agreement with Imperial College London and University of Leicester 10
Smith & Nephew Enters into Agreement with Imperial College London 11
Owlstone Medical Enters into Agreement with Imperial College London 12
Mauna Kea Technologies Enters Into Co-Development With Imperial College London 13
Medical Research Council, Imperial College, King's College and UCL Form Joint Venture 14
Imperial College London, King's College London, University College London, Medical Research Council And GSK Form Joint Venture 15
Imperial College London, Key Competitors 17
Imperial College London, Key Employees 18
Imperial College London, Subsidiaries 19
Imperial College London, Joint Venture 19

★海外企業調査レポート[Imperial College London-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Genera Biosystems Ltd (GBI):医療機器:M&Aディール及び事業提携情報
    Summary Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is …
  • Housing Development Finance Corporation Ltd:企業のM&A・事業提携・投資動向
    Housing Development Finance Corporation Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Housing Development Finance Corporation Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • VWR Corp (VWR)-医療機器分野:企業M&A・提携分析
    Summary VWR Corp (VWR) is a medical equipment company that distributes laboratory products, and provides services and solutions. The company offers product such chemicals, reagents, consumables, durable products, scientific equipment and instruments. It offers products in the areas of research and d …
  • Commonwealth Edison Company:電力:M&Aディール及び事業提携情報
    Summary Commonwealth Edison Company (ComEd) a subsidiary of Exelon Corporation is an electric utility that is engaged in the distribution of electricity to home and business customers. The utility’s business activities include lighting, retro-commissioning, HVAC, new construction, custom projects, i …
  • China Railway Group Ltd:企業の戦略・SWOT・財務情報
    China Railway Group Ltd - Strategy, SWOT and Corporate Finance Report Summary China Railway Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ontario Teachers’ Pension Plan:戦略・SWOT・企業財務分析
    Ontario Teachers' Pension Plan - Strategy, SWOT and Corporate Finance Report Summary Ontario Teachers' Pension Plan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Consort Medical plc (CSRT):医療機器:M&Aディール及び事業提携情報
    Summary Consort Medical plc (Consort Medical) is a contract development and manufacturing organization (CDMO) with focus on medical device technologies for drug delivery. It develops, manufactures and markets high volume disposable medical devices for drug delivery and point-of-care (POC) diagnostic …
  • Landstar System, Inc.:企業の戦略・SWOT・財務分析
    Landstar System, Inc. - Strategy, SWOT and Corporate Finance Report Summary Landstar System, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Gulf Power Co-エネルギー分野:企業M&A・提携分析
    Summary Gulf Power Company (Gulf Power), a subsidiary of Southern Company, is a vertically integrated energy utility which generates, procures, transmits, and distributes electricity. It generates electricity from coal and natural gas sources. The company has agreements with various industrial, comm …
  • CTD Holdings Inc (CTDH):企業の財務・戦略的SWOT分析
    Summary CTD Holdings Inc (CTDH), formerly Cyclodextrin Technologies Development Inc is a biotechnology company that develops, manufactures and distributes cyclodextrins products. The company’s products include aquaplex, trappsol and trappsol cyclo. It provides trappsol cyclo, which is a hydroxypropy …
  • Joint Stock Commercial Bank for Foreign Trade of Vietnam (VCB):企業の財務・戦略的SWOT分析
    Joint Stock Commercial Bank for Foreign Trade of Vietnam (VCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the c …
  • Ensco Plc (ESV):石油・ガス:M&Aディール及び事業提携情報
    Summary Ensco Plc (Ensco) is a provider of offshore drilling services to the global oil and gas industry. The company owns and operates fleet of drillships, semisubmersibles, moored semisubmersibles, premium jackups and deepwater managed units. It also provides drilling management services to custom …
  • EpiVax Inc-製薬・医療分野:企業M&A・提携分析
    Summary EpiVax Inc (EpiVax) is an immunology company which develops analytical capabilities in the field of computational immunology. Its product pipeline includes Tregitopes; deimmunization projects including deimmunized botox and deimmunized FVIII; and biodefense vaccines. Tregitopes are linear se …
  • AroCell AB (AROC):製薬・医療:M&Aディール及び事業提携情報
    Summary AroCell AB (AroCell), formerly Xi Bao Research AB, is a drug development company that develops and commercializes tests used for the prognosis and monitoring of treatment of cancer. The company develops TK 210 ELISA kits for measuring the enzyme TK1 which is a protein that is elevated in the …
  • Sembcorp Industries Ltd (U96):企業の財務・戦略的SWOT分析
    Sembcorp Industries Ltd (U96) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Euromoney Institutional Investor PLC:企業の戦略・SWOT・財務分析
    Euromoney Institutional Investor PLC - Strategy, SWOT and Corporate Finance Report Summary Euromoney Institutional Investor PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Advanced Accelerator Applications SA (AAAP):企業の財務・戦略的SWOT分析
    Summary Advanced Accelerator Applications SA (AAA), a Novartis company, is engaged in developing, producing and commercializing diagnostic and therapeutic molecular nuclear medicine products. The company’s lead product candidate comprises Lutathera, NETSPOT, SOMAKIT TOC, Gluscan, Gluscan 500, Barnas …
  • Akzo Nobel N.V.:企業の戦略・SWOT・財務情報
    Akzo Nobel N.V. - Strategy, SWOT and Corporate Finance Report Summary Akzo Nobel N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • SaskEnergy Inc:企業の戦略的SWOT分析
    SaskEnergy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • TapImmune Inc (TPIV):企業の財務・戦略的SWOT分析
    Summary TapImmune Inc (TapImmune) is a clinical-stage immuno-oncology company focus on the development of innovative peptide, gene-based immunotherapeutics and vaccines for the treatment of cancer and metastatic disease. The company’s pipeline products include TPIV 200, which is intended for the tre …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆